| Pregnant women on thyroxine substitution are often dysregulated in early pregnancy. | |
| | |
MedLine Citation:
|
PMID: 19207005 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
BACKGROUND: Thyroid hormones are important for normal fetal development. Maternal hypothyroidism during early pregnancy is associated with impaired neuropsychological development of children and other adverse outcomes. The primary aim of this prospective study was to determine whether thyroxine-treated pregnant women with hypothyroidism are adequately thyroxine substituted in early pregnancy. A secondary aim was to determine if fetal loss differed between females with thyrotropin (TSH) values within and outside the reference range at their first TSH test, scheduled for 1-2 weeks after verification of pregnancy. METHODS: This was a prospective open-labeled study. During the years 1997-2002, 119 consecutive pregnancies in 101 females with thyroid diseases were followed at the Department of Endocrinology, Malmö University Hospital. At the first visit, 63 patients, median age 30 years (range 17-45 years), were on thyroxine substitution therapy for hypothyroidism. In these patients 83% were in their first trimester at the time of the initial test. RESULTS: Of the 63 patients on thyroxine substitution for hypothyroidism 32 (51%; Group A) patients had serum TSH values within the reference range at their initial test and 31 (49%; Group B) had serum TSH values outside the reference range. Twelve (19%) had TSH values of <0.40 mIU=L and 19 (30%) had TSH values of >4.0 mIU=l. The fetal loss was 2 of 32 (6%) in Group A compared to 9 of 31 (29%) in Group B ( p < 0.05). CONCLUSIONS: In 49% of pregnant women on thyroxine substitution, serum TSH values were outside the reference range when first tested, generally in the first trimester. Fetal loss was significantly greater in pregnant women with abnormal TSH values compared to those with normal TSH values. Thyroid function in pregnant women on thyroxine substitution should be monitored early in pregnancy and carefully followed during pregnancy. The thyroxine dose should be increased as needed early in pregnancy to avoid hypothyroidism. |
| | |
Authors:
|
Bengt Hallengren; Mikael Lantz; Bengt Andreasson; Lars Grennert |
Related Documents
:
|
23085235 - Generalized disruption of inherited genomic imprints leads to wide-ranging placental de... 2371025 - Thyroxine requirement during pregnancy for replacement therapy of hypothyroidism. 20806345 - Prenatal diagnosis of fetal hypothyroidism after maternal radioactive iodine exposure d... 12975785 - Serial in utero ultrasonographic measurements of the fetal thyroid: a new complementary... 18043515 - Maternal anthropometrics in pregnancy are associated with left ventricular mass in infa... 3578425 - Hyperemesis gravidarum in relation to estradiol levels, pregnancy outcome, and other ma... |
Publication Detail:
|
Type: Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't |
Journal Detail:
|
Title: Thyroid : official journal of the American Thyroid Association Volume: 19 ISSN: 1557-9077 ISO Abbreviation: Thyroid Publication Date: 2009 Apr |
Date Detail:
|
Created Date: 2009-04-13 Completed Date: 2009-07-30 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9104317 Medline TA: Thyroid Country: United States |
Other Details:
|
Languages: eng Pagination: 391-4 Citation Subset: IM |
Affiliation:
|
Department of Endocrinology, Malmö University Hospital, Malmö, Sweden. bengt.hallengren@med.lu.se |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adolescent Adult Female Fetal Development Humans Hypothyroidism / drug therapy*, prevention & control Pregnancy Pregnancy Complications / blood, drug therapy* Pregnancy Trimester, First / blood Prospective Studies Thyrotropin / blood Thyroxine / blood, therapeutic use* |
| Chemical | |
Reg. No./Substance:
|
7488-70-2/Thyroxine; 9002-71-5/Thyrotropin |
| Comments/Corrections | |
Comment In:
|
Thyroid. 2009 Apr;19(4):323-6
[PMID:
19355821
]
|
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Thyroid carcinoma metastasis to skull with infringement of brain: treatment with radioiodine.
Next Document: Primary intrathoracic goiter: a rare and potentially serious entity.